RJA
MDC

Raymond James & Associates’s M.D.C. Holdings, Inc. MDC Stock Holding History

Raymond James & Associates’s Portfolio MDC Stock Details MDC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-137,811
Closed -$8.67M – 4129
2024
Q1 		$8.67M Sell
137,811
-761,044
-85% -$46.5M 0.01% 1246
2023
Q4 		$49.7M Buy
898,855
+168,214
+23% +$7.45M 0.04% 389
2023
Q3 		$30.1M Sell
730,641
-126,396
-15% -$5.89M 0.03% 526
2023
Q2 		$40.1M Sell
857,037
-62,021
-7% -$2.58M 0.03% 432
2023
Q1 		$35.7M Buy
919,058
+85,248
+10% +$3.15M 0.03% 454
2022
Q4 		$26.3M Sell
833,810
-71,380
-8% -$2.21M 0.02% 549
2022
Q3 		$24.8M Buy
905,190
+290,390
+47% +$9.61M 0.03% 527
2022
Q2 		$19.9M Sell
614,800
-129,509
-17% -$4.64M 0.02% 614
2022
Q1 		$28.2M Buy
744,309
+16,013
+2% +$731K 0.02% 554
2021
Q4 		$40.7M Buy
728,296
+62,591
+9% +$3.19M 0.03% 446
2021
Q3 		$31.1M Buy
665,705
+277,403
+71% +$14.1M 0.03% 513
2021
Q2 		$19.6M Buy
388,302
+10,440
+3% +$598K 0.02% 719
2021
Q1 		$22.4M Buy
377,862
+109,775
+41% +$5.75M 0.02% 615
2020
Q4 		$12.1M Buy
268,087
+4,009
+2% +$179K 0.01% 849
2020
Q3 		$11.5M Buy
264,078
+103,112
+64% +$4.11M 0.01% 791
2020
Q2 		$5.32M Buy
160,966
+24,794
+18% +$685K 0.01% 1146
2020
Q1 		$2.92M Buy
136,172
+47,516
+54% +$1.66M ﹤0.01% 1355
2019
Q4 		$3.13M Buy
88,656
+5,043
+6% +$190K ﹤0.01% 1552
2019
Q3 		$3.34M Sell
83,613
-19,252
-19% -$676K ﹤0.01% 1479
2019
Q2 		$3.12M Sell
102,865
-6,365
-6% -$187K ﹤0.01% 1515
2019
Q1 		$2.94M Buy
109,230
+7,595
+7% +$201K ﹤0.01% 1525
2018
Q4 		$2.45M Sell
101,635
-16,805
-14% -$406K ﹤0.01% 1522
2018
Q3 		$3M Sell
118,440
-5,182
-4% -$139K ﹤0.01% 1553
2018
Q2 		$3.26M Buy
123,622
+67,951
+122% +$1.77M 0.01% 1445
2018
Q1 		$1.33M Buy
55,671
+5,715
+11% +$151K ﹤0.01% 1942
2017
Q4 		$1.36M Buy
49,956
+3,561
+8% +$98.1K ﹤0.01% 1945
2017
Q3 		$1.22M Sell
46,395
-2,729
-6% -$72.1K ﹤0.01% 1973
2017
Q2 		$1.38M Buy
49,124
+4,044
+9% +$106K ﹤0.01% 1821
2017
Q1 		$1.07M Buy
45,080
+12,157
+37% +$274K ﹤0.01% 1932
2016
Q4 		$671K Buy
32,923
+8,485
+35% +$158K ﹤0.01% 2155
2016
Q3 		$454K Buy
24,438
+5,294
+28% +$98.4K ﹤0.01% 2355
2016
Q2 		$335K Buy
19,144
+3
+0% +$52 ﹤0.01% 2345
2016
Q1 		$345K Buy
19,141
+1
+0% +$16 ﹤0.01% 2238
2015
Q4 		$352K Sell
19,140
-1,399
-7% -$26.5K ﹤0.01% 2138
2015
Q3 		$387K Buy
20,539
+1,404
+7% +$29.4K ﹤0.01% 2031
2015
Q2 		$413K Buy
19,135
+1
+0% +$20 ﹤0.01% 2169
2015
Q1 		$393K Sell
19,134
-683
-3% -$13.1K ﹤0.01% 2131
2014
Q4 		$378K Buy
19,817
+1
+0% +$18 ﹤0.01% 2056
2014
Q3 		$361K Buy
19,816
+2
+0% +$40 ﹤0.01% 1971
2014
Q2 		$432K Sell
19,814
-5,267
-21% -$108K ﹤0.01% 1908
2014
Q1 		$511K Sell
25,081
-346
-1% -$7.41K ﹤0.01% 1778
2013
Q4 		$590K Sell
25,427
-1,243
-5% -$26.4K ﹤0.01% 1597
2013
Q3 		$576K Buy
26,670
+282
+1% +$6.2K 0.01% 1529
2013
Q2 		$618K Buy
+26,388
New +$686K 0.01% 1413

Other funds holding MDC

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
WIA
Wetzel Investment Advisors Indianapolis, Indiana $252M AUM 18.78% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Raymond James & Associates's MDC Position: Q2 2024 in Review

Raymond James & Associates sold out of M.D.C. Holdings, Inc. (MDC) in Q2 2024, closing a stake of 137,811 shares — an estimated $8.67M sold.

Raymond James & Associates first reported a position in MDC in Q2 2013 and held it in 44 quarters. The position peaked at $49.7M in Q4 2023. 4 funds tracked by Wall St. Rank hold MDC as of Q2 2024.

  • Raymond James & Associates reported no remaining M.D.C. Holdings, Inc. position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 137,811 M.D.C. Holdings, Inc. shares in Q2 2024, an estimated $8.67M.
  • Raymond James & Associates first reported a position in M.D.C. Holdings, Inc. in Q2 2013 and held it in 44 quarters.
  • Raymond James & Associates's M.D.C. Holdings, Inc. position peaked at $49.7M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held M.D.C. Holdings, Inc. as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.